GNH USA

Europe — EMA

Mecolzup

GNH USA supplies Mecolzup (Mesalazine), a 5‑aminosalicylic acid derivative for distal ulcerative colitis. Request a quote for global supply.

Mesalazine

Request sourcing

1
Pack/s

What is Mesalazine?

Mesalazine, the active ingredient in Mecolzup, is a 5‑aminosalicylic acid (5‑ASA) derivative presented as a rectal formulation for local use. It is indicated for the treatment of distal ulcerative colitis in adult patients, providing topical anti‑inflammatory activity directly at the site of disease. GNH USA supplies Mecolzup as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Mesalazine used for?

Mecolzup is a 5‑ASA drug used in the management of ulcerative colitis, a chronic inflammatory bowel disease. - Distal ulcerative colitis: helps achieve clinical remission and promotes mucosal healing. - Ulcerative colitis (mild to moderate): provides topical anti‑inflammatory effect to reduce symptoms. - Maintenance of remission in distal ulcerative colitis: sustains symptom control after induction therapy.

What are the side effects of Mesalazine?

Mecolzup may cause a range of adverse reactions, most of which are mild and related to its rectal administration.

Common Side Effects: - Rectal irritation or burning sensation. - Urgency to defecate. - Abdominal cramping or pain. - Nausea. - Headache. - Flatulence.

Serious or Rare Side Effects: - Allergic reaction (rash, itching, swelling). - Severe colitis flare or worsening of symptoms. - Blood in stool. - Elevated liver enzymes. - Pancreatitis. - Severe hypersensitivity (e.g., anaphylaxis).

What precautions apply to Mesalazine?

Before using Mecolzup, certain safety considerations should be observed. - Pregnancy: consult a physician; safety data are limited. - Breastfeeding: weigh potential benefits against possible risks to the infant. - Renal impairment: monitor renal function regularly. - Concomitant NSAIDs: may increase risk of renal toxicity. - Hypersensitivity: avoid if known allergy to mesalazine or other salicylates. - Store at room temperature: keep in the original container, protect from moisture and light.

What does Mesalazine interact with?

Mecolzup can interact with several medicines; awareness of these interactions helps minimize risk.

Major Interactions (Avoid): - Azathioprine: increased risk of bone‑marrow suppression. - Methotrexate: additive toxicity, especially hepatic. - Warfarin or other anticoagulants: may enhance anticoagulant effect.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase renal toxicity. - Oral contraceptives: may reduce contraceptive efficacy.

Frequently asked questions

What is Mecolzup used for?+
Mecolzup contains mesalazine and is prescribed for the treatment of distal ulcerative colitis. It works as a topical anti‑inflammatory agent to reduce inflammation in the lower part of the colon, helping to induce remission and control symptoms in patients with mild to moderate disease.
How does mesalazine work in Mecolzup?+
Mesalazine exerts its effect by inhibiting cyclooxygenase and lipoxygenase enzymes in the colonic mucosa, which lowers prostaglandin and leukotriene production. It also scavenges free radicals, decreasing oxidative stress and limiting the activation of inflammatory cells, thereby reducing mucosal inflammation.
What is the usual dose of Mecolzup?+
The dosage of Mecolzup is determined by the prescribing clinician based on the severity of disease, patient weight, and response to therapy. Healthcare professionals tailor the regimen to each individual, and patients should follow the specific instructions provided by their prescriber.
Is Mecolzup safe during pregnancy or breastfeeding?+
Safety data for mesalazine in pregnancy are limited, so the benefits and risks should be evaluated by a healthcare professional. During breastfeeding, the drug may be excreted in milk; clinicians usually consider the therapeutic need versus potential exposure to the infant before recommending use.
How do I order Mecolzup from GNH USA?+
To place an order, submit an enquiry on the Mecolzup product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Mecolzup compare with other ulcerative colitis treatments?+
Mecolzup delivers mesalazine directly to the rectum, offering a targeted anti‑inflammatory effect with minimal systemic exposure compared with oral 5‑ASA formulations. This can result in fewer systemic side effects, but it is limited to distal disease. Other options, such as oral mesalazine or biologics, may be chosen for extensive colitis or refractory cases.
What are the storage and handling requirements for Mecolzup?+
Mecolzup should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.
How is Mecolzup administered?+
Mecolzup is a rectal formulation that is inserted into the rectum using the supplied applicator or an appropriate enema device. The patient should follow the prescriber’s instructions regarding frequency and position (often lying on the left side) to ensure optimal distribution of the medication.
What are the most serious risks associated with Mecolzup?+
Serious risks include severe allergic reactions such as rash, swelling or anaphylaxis, and worsening of colitis symptoms, which may present as increased bleeding or abdominal pain. Rarely, mesalazine can cause liver enzyme elevations, pancreatitis, or blood dyscrasias, all of which require immediate medical attention.
Who should not use Mecolzup?+
Mecolzup should be avoided in individuals with a known hypersensitivity to mesalazine, other 5‑ASA compounds, or salicylates. Patients with severe renal impairment, active severe ulcerative colitis requiring systemic therapy, or those taking interacting medications without proper monitoring should not use this product without medical guidance.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Mesalazine
Route
Rectal Use
Manufacturer
Innovis Pharma
Origin
EU

Related products